Key Takeaway
Review of BPC-157's musculoskeletal healing mechanisms shows it accelerates tendon, ligament, and muscle repair through angiogenesis promotion, inflammation modulation, and growth factor upregulation.
Summary
This review examines the role of BPC-157 in accelerating musculoskeletal soft tissue healing, focusing on tendons, ligaments, and muscles. The authors consolidate findings from preclinical studies to characterize BPC-157's mechanisms of action and therapeutic potential for sports and orthopedic injuries.
BPC-157 was shown to promote healing through several key pathways: stimulation of angiogenesis via increased VEGF expression, modulation of inflammatory responses, upregulation of growth hormone receptors in injured tissue, and activation of the FAK-paxillin signaling pathway critical for tendon and ligament repair. The peptide also demonstrated the ability to counteract the negative effects of corticosteroids and NSAIDs on tissue healing.
The review highlights BPC-157's unique stability in gastric juice (unlike most peptides) and its efficacy across multiple administration routes including subcutaneous injection and oral delivery. While the authors conclude that BPC-157 shows strong promise for musculoskeletal soft tissue repair, they emphasize the need for human clinical trials to translate these preclinical findings into evidence-based clinical practice.